Want to join the conversation?
$STZ expects diluted EPS accretion from the Meiomi acquisition to be around $0.07-0.08 in FY16 versus the previous $0.03-0.04 projection. On a comparable basis, the Ballast Point acquisition is expected to be neutral to diluted EPS for FY16 and $0.05-0.06 accretive for FY17.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.